GENE ONLINE|News &
Towards Exosome-Based Theranostics for Alzheimer’s Disease
With high biocompatibility combined with the ability to pass through BBB and carry drug payloads, exosomes have huge potential in treating AD.
Exosomes by themselves or as vehicles for drug delivery offer a Trojan horse strategy that could be exploited for treatments. In summary, the utilization of exosomes as novel theranostics offers hope in treating a devastating disease like AD.
Exosomes by themselves or as vehicles for drug delivery offer a Trojan horse strategy that could be exploited for treatments. In summary, the utilization of exosomes as novel theranostics offers hope in treating a devastating disease like AD.
GO Prime with only $1.49 now
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
